# Optimal MTX Dose With Folic Acid Randomized Case-control Trial

> **NCT04066803** · PHASE4 · UNKNOWN · sponsor: **Sun Yat-sen University** · enrollment: 160 (estimated)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** MTX
- **DRUG:** Folic Acid
- **DRUG:** DMARDs

## Key facts

- **NCT ID:** NCT04066803
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-08-01
- **Primary completion:** 2020-07-30
- **Final completion:** 2020-07-30
- **Target enrollment:** 160 (ESTIMATED)
- **Last updated:** 2019-08-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04066803

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04066803, "Optimal MTX Dose With Folic Acid Randomized Case-control Trial". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04066803. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*